Celularity (CELU) Market Capitalization (2019 - 2025)
Celularity's (CELU) quarterly Market Capitalization came in at $32.0 million in Q4 2025, down 49.66% year-over-year from $63.6 million in Q4 2024, and down 45.2% quarter-over-quarter from $58.4 million in Q3 2025.
Analysis
Celularity (CELU) Market Capitalization (2019 - 2025) Analysis & Trends
Celularity (CELU) has reported Market Capitalization for 7 consecutive years, with $32.0 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Market Capitalization fell 49.66% year-over-year to $32.0 million in Q4 2025; TTM through Dec 2025 was $32.0 million, a 49.66% decrease from a year earlier, with the FY2025 full-year figure at $32.0 million, down 49.66% from the prior year.
- Market Capitalization was $32.0 million for Q4 2025 at Celularity, down from $58.4 million in the prior quarter.
- Over five years, Market Capitalization peaked at $1.2 billion in Q1 2022 and troughed at $32.0 million in Q4 2025.
- A 5-year average of $250.3 million and a median of $99.3 million in 2023 frame the typical range for Market Capitalization.
- Across the five-year window, Market Capitalization surged 860.34% in 2021 and plunged 91.47% in 2023, its largest moves.
- Over 5 years, Market Capitalization stood at $343.3 million in 2021, then slumped by 44.05% to $192.1 million in 2022, then plunged by 75.08% to $47.9 million in 2023, then jumped by 32.85% to $63.6 million in 2024, then plunged by 49.66% to $32.0 million in 2025.
- The last three Market Capitalization figures came in at $32.0 million (Q4 2025), $58.4 million (Q3 2025), and $59.9 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 32.01 Mn |
| Sep 30, 2025 | 58.41 Mn |
| Jun 30, 2025 | 59.92 Mn |
| Mar 31, 2025 | 52.89 Mn |
| Dec 31, 2024 | 63.59 Mn |
| Sep 30, 2024 | 90.79 Mn |
| Jun 30, 2024 | 95.68 Mn |
| Mar 31, 2024 | 114.06 Mn |
| Dec 31, 2023 | 47.86 Mn |
| Sep 30, 2023 | 42.99 Mn |
| Jun 30, 2023 | 96.38 Mn |
| Mar 31, 2023 | 102.32 Mn |
| Dec 31, 2022 | 192.11 Mn |
| Sep 30, 2022 | 333.85 Mn |
| Jun 30, 2022 | 484.11 Mn |
| Mar 31, 2022 | 1.20 Bn |
| Dec 31, 2021 | 343.33 Mn |
| Sep 30, 2021 | 874.13 Mn |
| Jun 30, 2021 | 358.82 Mn |
| Mar 31, 2021 | 362.25 Mn |